Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral ST1481 in Adults With Malignant Glioma: a Phase I-II Clinical Trial

NCT00032903 is registered in ClinicalTrials.gov with Sigma-Tau Research, Inc. as lead sponsor.

NCT NCT00032903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00032903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral ST1481 in Adults With Malignant Glioma: a Phase I-II Clinical Trial
Lead sponsor
Sigma-Tau Research, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2002
Completion date
October 31, 2005
Enrollment
59 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant glioma